Good News for People in Salvage Therapy: Merck to start its expanded access program for its integrase inhibitor MRK 518
I am very excited about this expanded access of Merck’s integrase inhibitor, MRK 518. I have been taking it for 3 months now with the new protease (Prezista) and have been able to reach undetectable viral load for the first time in 23 years. My CD4 cells have more than doubled from 180 to 440 […]